Challenges in SEND Conversion of EFD Studies in Comply with the SENDIG-DART v1.1 and Practical Examples Addressing the CDISC SEND Conformance Rules v4.0 and Reviewed Results Published by the FDA
Released on J-STAGE: August 25, 2022 |
The 49th Annual Meeting of the Japanese Society of Toxicology
P-269
* Susumu SUYAMA, Shin-ichi HORIKAWA, Konomi IINO, Tadashi USHIMARU, Atsushi UEMATSU, Shin-ichi SATO, Takayuki ANZAI